Mejia, Miecel C.

HRN: 23-78-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFUROXIME 500MG (TAB)
09/29/2023
10/06/2023
PO
500mg
BID X 7 Days
S/P NSVD To A Stillborn
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: